Genetic LifeSpan, a specialist in precision wellness, longevity intelligence, and preventive health innovation, has published its peer-reviewed scientific review article, “From Biological Age to Clinical Phenotype: State of the Science in DNA Methylation, Multi-Omic Clocks, and Translational Utility”, in the American Journal of Biomedical Science and Research
The publication analyses the evolving science of biological age testing, DNA methylation analysis, polygenic risk scoring, multi-omic biomarkers, and organ-system ageing assessments.
The review emphasises how biological age technologies are transforming healthcare by facilitating earlier risk detection, personalised interventions, and objective monitoring of health outcomes.
The paper was co-authored by an interdisciplinary team of scientists, physicians, and researchers including Jonathan R.T. Lakey, PhD, Laura Capina, PhD, Jeffery M. Gaal, Jaime Raijman, Elliott Greenspan, Ian Jenkins, Krista Casazza, and Adam Vincent Gilmer.
According to the publication, chronological age on its own is an incomplete measure of health and disease risk. Biological age assessments provide a more comprehensive understanding of how genetics, lifestyle, environment, inflammation, metabolism, immune function, and organ-system health contribute to someone’s ageing trajectory.
The review discusses how biological age measurements can serve as tools for monitoring the effectiveness of interventions such as exercise, nutrition programs, regenerative medicine, stem cell therapies, peptide protocols, hyperbaric oxygen therapy, red light therapy, and other longevity-focused approaches. The publication strengthens the scientific consensus that biological age may provide a more actionable measure of health than chronological age on its own.
AgeCode Premier, Genetic LifeSpan’s biological intelligence platform, combines genomic analysis, DNA methylation measurements, and multi-system biomarker profiling for a comprehensive view of biological ageing, pace of ageing, organ-system health, inherited predispositions, and wellness optimisation opportunities.
Adam Vincent Gilmer, founder and CEO of Genetic LifeSpan, said, “Healthcare is undergoing a fundamental shift from reactive disease management to proactive health optimisation. Objective biological intelligence allows physicians and individuals to measure what is working instead of relying on assumptions. We believe the future belongs to those who don’t guess; they test.”
AgeCode represents a new category of healthcare where individuals can improve their understanding of how they age, identify risks sooner, personalise their wellness strategies, and track outcomes over time.
Dr Jonathan R.T. Lakey, a member of the Genetic LifeSpan Scientific Advisory Board and co-author of the publication, said, “Biological age represents one of the most promising frontiers in translational medicine. The ability to integrate genomic, epigenetic, and biomarker data provides unprecedented insight into how individuals are ageing across multiple organ systems. Our goal is to help move healthcare toward earlier intervention, more precise decision-making, and ultimately improved healthspan and quality of life. The future of medicine is not simply treating disease after it occurs; it is identifying risk earlier, understanding biological function more comprehensively, and empowering physicians with better tools to guide prevention and optimisation. Biological age testing is a significant step toward that future.”
Genetic LifeSpan has shared that it believes biological age testing will become a foundational component of modern healthcare, longevity medicine, concierge medicine, functional medicine, integrative medicine, regenerative medicine, and preventive wellness programs.
AgeCode Premier offers an opportunity to establish objective patient baselines, personalise treatment strategies, monitor intervention effectiveness, enhance patient engagement, and create measurable outcomes to support long-term health optimisation.
AgeCode also provides a data-driven roadmap to improve self-care, helping individuals to understand how they are ageing, where potential vulnerabilities may exist, and what actions could support their long-term health.
